$WHWK SEC Filings

Filed On	Filing
18 Sep 2026	Form 4/A: Lennon David James, Director Granted 193,957 Stock option (right to buy) · Granted 193,957 Restricted Stock Units
18 Sep 2026	Form 4/A: Dugan Margaret, Chief Medical Officer Granted 81,250 Stock Option (right to buy) · Granted 81,250 Restricted Stock Units
18 Sep 2026	Form 4/A: Dornan David, Chief Scientific Officer Granted 85,887 Stock Option (right to buy) · Granted 85,887 Restricted Stock Units
18 Sep 2026	Form 4/A: Ball Bryan, See remarks Granted 91,633 Stock Option (right to buy) · Granted 91,633 Restricted Stock Units
18 Sep 2026	Form 4/A: Giacobello Scott M., CHIEF FINANCIAL OFFICER Granted 118,476 Stock Option (right to buy) · Granted 118,476 Restricted Stock Units
15 Sep 2026	Form 4: Lennon David James, Director Granted 193,957 Stock option (right to buy) · Granted 193,957 Restricted Stock Units
15 Sep 2026	Form 4: Dugan Margaret, Chief Medical Officer Granted 81,250 Stock Option (right to buy) · Granted 81,250 Restricted Stock Units
15 Sep 2026	Form 4: Dornan David, Chief Scientific Officer Granted 85,887 Stock Option (right to buy) · Granted 85,887 Restricted Stock Units
15 Sep 2026	Form 4: Ball Bryan, See remarks Granted 91,633 Stock Option (right to buy) · Granted 91,633 Restricted Stock Units
15 Sep 2026	Form 4: Giacobello Scott M., CHIEF FINANCIAL OFFICER Granted 118,476 Stock Option (right to buy) · Granted 118,476 Restricted Stock Units
11 Sep 2026	Form 4: Iyengar Vijay K, Director Granted 76,080 Stock Option (right to buy)
11 Sep 2026	Form 3: Iyengar Vijay K, Director No securities owned
10 Sep 2026	8-K: Departure/Election of Directors or Officers; Compensation Former Incyte Executive Brings Extensive Oncology, Corporate Strategy, Business Development and Medical Affairs Experience
14 Aug 2026	SCHEDULE 13G/A
14 Aug 2026	SCHEDULE 13G/A
06 Aug 2026	10-Q
06 Aug 2026	8-K: Results of Operations and Financial Condition
30 Jul 2026	Form 4: Dalal Anupam, Director Received 1,275,510 shares as a grant or award ($5M) · Granted 38,040 Stock Option (right to buy)
15 Jun 2026	Form 4: Zhao Baiteng, Director Granted 38,040 Stock Option (right to buy)
15 Jun 2026	Form 4: Reeve Emma, Director Granted 38,040 Stock Option (right to buy)

Comments